Back to search

Article

<i>In Vivo</i> CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy Target

2020-12-10

Abstract excerpt

<h4>SUMMARY</h4> Despite remarkable clinical efficacies of immune checkpoint blockade (ICB) in cancer treatment, ICB benefits in triple-negative breast cancer (TNBC) remain limited. Through pooled in vivo CRISPR knockout (KO) screens in syngeneic TNBC mouse models, we found that inhibition of the E3 ubiquitin ligase Cop1 in cancer cells decreases the secretion of macrophage-associated chemokines, reduces tumor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4a63a57-3ccd-53ad-a4b1-c7af14f1aeba
DOI
10.1101/2020.12.09.418012
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In Vivo</i> CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy TargetDOI 10.1101/2020.12.09.418012
Select a neighboring publication to make it the new centre.